Tag: Nova Mentis - Page 2 - Psychedelic Alpha

Read more about the article Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics

Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics

Post published:July 29, 2021
Post category:Press Release

Read more about the article Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer

Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer

Post published:July 15, 2021
Post category:Press Release

Read more about the article Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

Post published:June 23, 2021
Post category:Press Release

Read more about the article Nova Mentis Launches Autism Clinical Study

Nova Mentis Launches Autism Clinical Study

Post published:May 6, 2021
Post category:Press Release

Read more about the article Nova Mentis Organizes Autism Data Bank in North America

Nova Mentis Organizes Autism Data Bank in North America

Post published:April 20, 2021
Post category:Press Release

Read more about the article Nova Mentis Establishes Serotonin Research Centre

Nova Mentis Establishes Serotonin Research Centre

Post published:March 31, 2021
Post category:Press Release

Read more about the article Nova Mentis Announces Promising Research Results

Nova Mentis Announces Promising Research Results

Post published:March 29, 2021
Post category:Press Release

Read more about the article Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Post published:March 10, 2021
Post category:Press Release

Read more about the article Nova Mentis Launches Autism Microbiome Study in the United States

Nova Mentis Launches Autism Microbiome Study in the United States

Post published:March 3, 2021
Post category:Press Release

Read more about the article Nova Mentis Autism Clinical Study Approved by Institutional Review Board

Nova Mentis Autism Clinical Study Approved by Institutional Review Board

Post published:February 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.